April 27, 2021 (LifeSiteNews) — One mantra that emerged from the COVID-19 pandemic is “follow the science,” which suggests that health and social policy should be guided by scientific research. If this principle applies to a virus threat, why doesn’t it guide policy on gender identity disorder (GID)?
On March 24, the Senate confirmed President Biden’s choice for assistant secretary of health — a male pediatrician who claims to be a woman: “Rachel” Levine. Lambda Legal, which promotes LGBTQ civil rights, praised Levine’s confirmation as marking “the return of science, competence, and empathy to one of the most important institutions in our government.”
Touting Levine’s confirmation as “the return to science [and] competence,” however, is a questionable assertion. Yes, an article posted by American Family Physician claims that “gender-affirming hormone therapy … is generally safe” and that “those who receive treatment generally report improved quality of life and self-esteem.” But the same article admits that “transgender patients typically have high rates of mental health diagnoses” and that primary care physicians should “consider routine screening” for a number of mental health conditions, including depression, anxiety, eating disorders, and suicidal proclivity. Physicians should also look for signs and symptoms of metabolic disease
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
